A highly selective and potent HPK1 inhibitor enhances immune cell activation and induces robust tumor growth inhibition in a murine syngeneic tumor model

被引：0
|
作者：
Ciccone, D. [1 ]
Lazari, V. [2 ]
Linney, I. [2 ]
Briggs, M. [2 ]
Carreiro, S. [1 ]
Waddell, I. [2 ]
Hill, C. [2 ]
Loh, C. [1 ]
Tummino, P. [1 ]
Collis, A. [1 ]
Kaila, N. [1 ]
机构：
[1] Nimbus Therapeut, Res & Dev, Cambridge, MA USA
[2] Charles River Labs, Res, Chesterford Pk, England
来源：
EUROPEAN JOURNAL OF CANCER | 2020年 / 138卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
46
引用
收藏
页码：S20 / S20
页数：1
相关论文
共 50 条
  • [31] eFT508, a potent and highly selective inhibitor of MNK1 and MNK2, is an activator of anti-tumor immune response
    Webster, Kevin
    Sharma, Rajesh
    Goel, Vikas
    Stumpf, Craig
    Stauton, Jocelyn
    Thompson, Peggy
    Chiang, Gary
    Xu, Yichen
    Jin, Hyun Yong
    Ruggero, Davide
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2017, 5
  • [32] PD-1 blockade enhances the anti-tumor immune response induced by cryoablation in a murine model of renal cell carcinoma
    Zhu, Chenzhuang
    Lin, Sihao
    Liang, Junhao
    Zhu, Yingjian
    CRYOBIOLOGY, 2019, 87 : 86 - 90
  • [33] Galectin-1 Inhibitor OTX008 Induces Tumor Vessel Normalization and Tumor Growth Inhibition in Human Head and Neck Squamous Cell Carcinoma Models
    Koonce, Nathan A.
    Griffin, Robert J.
    Dings, Ruud P. M.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2017, 18 (12)
  • [34] ITI-214, a potent and selective PDE1 inhibitor, inhibits tumor growth when combined with a checkpoint inhibitor in a mouse model of breast cancer
    Voisin, Maud
    Goding, Stephen
    Snyder, Gretchen L.
    Davis, Robert E.
    CANCER RESEARCH, 2022, 82 (12)
  • [35] A small molecule human PD-1/PD-L1 inhibitor promotes T cell immune activation and reduces tumor growth in a preclinical model
    Colomer, M. Vilalta
    Punna, S.
    Li, S.
    Malathong, V.
    Lange, C.
    McMurtrie, D.
    Yang, J.
    Roth, H.
    McMahon, J.
    Campbell, J. J.
    Ertl, L. S.
    Ong, R.
    Wang, Y.
    Zhao, N.
    Yau, S.
    Dang, T.
    Zhang, P.
    Schall, T. J.
    Singh, R.
    ANNALS OF ONCOLOGY, 2018, 29
  • [36] Tumor growth inhibition and immune system activation following treatment with thorium-227 conjugates and PD-1 check-point inhibition in the MC-38 murine model
    Berg-Larsen, Axel
    Mobergslien, Anne
    Moen, Ingrid
    Petros, Gebregziabher
    Kristian, Alexander
    Gunvaldsen, Kristine Sponheim
    Cruciani, Veronique
    Wickstroem, Katrine
    Bjerke, Roger Malerbakken
    Karlsson, Jenny
    Cuthbertson, Alan
    FRONTIERS IN MEDICINE, 2022, 9
  • [37] Inhibition of tumor growth through suppression of angiogenesis by brain-specific angiogenesis inhibitor 1 gene transfer in murine renal cell carcinoma
    Kudo, Shigetaka
    Konda, Ryuichiro
    Obara, Wataru
    Kud, Daisuke
    Tan, Kenzaburo
    Nakamura, Yusuke
    Fujika, Tomoaki
    ONCOLOGY REPORTS, 2007, 18 (04) : 785 - 791
  • [38] eFT508, a potent and highly selective inhibitor of MNK1/2 regulates immune checkpoint and cytokine expression promoting anti-tumor immunity
    Webster, Kevin R.
    Goel, Vikas K.
    Staunton, Jocelyn
    Stumpf, Craig R.
    Sharma, Rajesh
    Hung, Ivy N.
    Parker, Gregory S.
    Molter, Jolene
    Chiang, Gary G.
    Wegerski, Christopher J.
    Sperry, Samuel
    Huang, Vera
    Chen, Joan
    Thompson, Peggy A.
    Tran, Chinh
    Ernst, Justin T.
    Sprengeler, Paul A.
    Reich, Siegfried H.
    CANCER RESEARCH, 2017, 77
  • [39] SU5416: A potent and selective Flk-1/KDR kinase inhibitor that blocks receptor autophosphorylation, endothelial cell mitogenesis, and tumor growth
    Tang, C
    Li, S
    Tran, J
    Liang, C
    Nematalla, A
    Fong, A
    App, H
    Rice, A
    Kim, Y
    Schreck, R
    Chen, J
    Dowd, B
    Suto, E
    Vasile, S
    Shawver, L
    McMahon, J
    Hirth, P
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1998, 215 : U920 - U920
  • [40] AZD1152, highly potent Aurora kinase inhibitor, with selectivity for Aurora kinase B, induces pharmacodynamic effects and significant growth inhibition in human tumor xenograft models.
    Wilkinson, RW
    Odedra, R
    Heaton, SP
    Keen, N
    Wedge, SR
    Brown, E
    Crafter, C
    Foote, KM
    Mortlock, AA
    Jung, FH
    Heron, NM
    Brady, MC
    Khatri, L
    Foster, JJ
    Green, S
    CLINICAL CANCER RESEARCH, 2005, 11 (24) : 9085S - 9085S
12345